Economic Impact of Adopting ZedScan

An independent analysis of the economic impact on the use of ZedScan as an adjunct to colposcopy was performed by the University of Sheffield, School of Health and Related  Research (ScHARR). They concluded that the use of ZedScan resulted in a "lower total cost" and  "lower cost per women with CIN2+ treated than for colposcopy alone". 1

Reduction in Costs

The decrease in total costs was attributed to:
  • Significant reduction in the histology burden and costs for histological analysis as a result of the decrease in the number of biopsies required when compared with colposcopy alone
  • Reduction in the number of follow up appointments required
  • Women identified as having High Grade disease (CIN2/CIN3) could be treated at first visit while those with no cervical abnormalities or Low Grade CIN  (CIN1 or less) could be returned to routine surveillance, releasing clinic time and freeing up resources

Opportunities arising from released appointments

The reduction in appointments also provides clinicians with options as to how to utilise the released clinic time and further improve efficiency. e.g.

  • Decrease in colposcopy waiting times resulting in a higher patient throughput
  • Re-allocation to other gynaecological procedures providing a further source of income for the clinic
zedscan health economics graphic

1 Whyte S, Bessey A, Chilcott J. "Economic Evaluation of the ZedScan Electrical Impedance Spectroscopy (EIS) Device used as an adjunct to colposcopy." (2013) School of Health and Related Research (ScHARR), The University of Sheffield.